Kevin Smith
News Writer
Discover our authors
Vertex Pharmaceuticals Incorporated : Vertex and Crispr to market $2.2 million treatment for sickle cell disease
The U.S. Food and Drug Administration has approved the marketing of two gene therapies for sickle cell disease, including the first treatment based on Crispr technology. These extremely costly treatments address a major medical need, affecting around 100,000 people in the USA alone.
December 11, 2023 at 05:47 am EST
British American Tobacco p.l.c. : Go smoke go broke
Cigarette maker British American Tobacco plummets after unexpectedly taking a £25bn impairment charge. In a press release, it acknowledges that its fuel business has "no long-term future", and revises the book value of its brands accordingly.
December 07, 2023 at 10:48 am EST
- Stock Market
- Our authors
- Kevin Smith